Superhydrophobic hemostatic nanofiber composites for fast clotting and minimal adhesion.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
05 12 2019
Historique:
received: 26 10 2018
accepted: 11 11 2019
entrez: 6 12 2019
pubmed: 6 12 2019
medline: 17 3 2020
Statut: epublish

Résumé

Hemostatic materials are of great importance in medicine. However, their successful implementation is still challenging as it depends on two, often counteracting, attributes; achieving blood coagulation rapidly, before significant blood loss, and enabling subsequent facile wound-dressing removal, without clot tears and secondary bleeding. Here we illustrate an approach for achieving hemostasis, rationally targeting both attributes, via a superhydrophobic surface with immobilized carbon nanofibers (CNFs). We find that CNFs promote quick fibrin growth and cause rapid clotting, and due to their superhydrophobic nature they severely limit blood wetting to prevent blood loss and drastically reduce bacteria attachment. Furthermore, minimal contact between the clot and the superhydrophobic CNF surface yields an unforced clot detachment after clot shrinkage. All these important attributes are verified in vitro and in vivo with rat experiments. Our work thereby demonstrates that this strategy for designing hemostatic patch materials has great potential.

Identifiants

pubmed: 31804481
doi: 10.1038/s41467-019-13512-8
pii: 10.1038/s41467-019-13512-8
pmc: PMC6895059
doi:

Substances chimiques

Hemostatics 0
Fibrin 9001-31-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5562

Références

Clin Chem Lab Med. 2007;45(5):565-76
pubmed: 17484616
J Pharmacol Pharmacother. 2010 Jul;1(2):87-93
pubmed: 21350616
Arthritis Rheum. 2011 Oct;63(10):3067-77
pubmed: 21702008
Thromb Res. 2008;123(1):146-58
pubmed: 18479740
J Pharm Sci. 2015 Nov;104(11):3653-3680
pubmed: 26308473
Nat Mater. 2017 Feb;16(2):230-235
pubmed: 27723740
ACS Appl Mater Interfaces. 2017 Apr 5;9(13):11790-11797
pubmed: 28319366
Biomaterials. 2016 Oct;104:87-103
pubmed: 27449946
Adv Mater. 2018 Jun;30(24):e1705104
pubmed: 29465772
Lancet. 2016 Jul 9;388(10040):187-97
pubmed: 26897598
Biomaterials. 2011 May;32(13):3351-7
pubmed: 21296412
ACS Appl Mater Interfaces. 2016 Jan 13;8(1):651-9
pubmed: 26595458
J Colloid Interface Sci. 2004 Jul 15;275(2):488-95
pubmed: 15178277
Mol Syst Biol. 2011 Aug 16;7:521
pubmed: 21847113
Nanomedicine. 2015 Jan;11(1):39-46
pubmed: 25072378
ACS Biomater Sci Eng. 2015 Jun 8;1(6):440-447
pubmed: 33445247
Biotechnol Bioeng. 2003 Nov 5;84(3):305-13
pubmed: 12968284
Adv Drug Deliv Rev. 2018 Apr;129:394-406
pubmed: 29408181
Nat Mater. 2011 Jan;10(1):61-6
pubmed: 21131961
Adv Healthc Mater. 2018 Apr;7(7):e1701086
pubmed: 29334429
Colloids Surf B Biointerfaces. 2018 Jun 1;166:179-186
pubmed: 29579729
Langmuir. 2014 Sep 23;30(37):11165-74
pubmed: 25157934
J Trauma. 2010 Feb;68(2):269-78
pubmed: 20154537
J Thromb Haemost. 2005 Aug;3(8):1894-904
pubmed: 16102057
Nat Commun. 2017 Nov 2;8(1):1274
pubmed: 29097692
ACS Appl Mater Interfaces. 2018 Jan 24;10(3):2907-2917
pubmed: 29286629
Eur Radiol. 2011 Aug;21(8):1687-91
pubmed: 21476127
Biomed Pharmacother. 2017 Dec;96:104-111
pubmed: 28968538
J Mater Chem B. 2014 Nov 7;2(41):7186-7191
pubmed: 32261797
Arch Intern Med. 2003 Aug 11-25;163(15):1849-56
pubmed: 12912723
J Mater Sci Mater Med. 2000 Aug;11(8):517-21
pubmed: 15348003
Colloids Surf B Biointerfaces. 2015 Aug 1;132:27-33
pubmed: 26001799
Mol Immunol. 2006 Feb;43(3):193-201
pubmed: 16199256
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 Sep;9(5):
pubmed: 28078811
J Trauma. 2008 Feb;64(2 Suppl):S21-6; discussion S26-7
pubmed: 18376168
Nat Protoc. 2018 Jul;13(7):1521-1538
pubmed: 29988109
J Surg Res. 2015 Jan;193(1):316-23
pubmed: 25016441
Radiology. 1985 Jan;154(1):234-5
pubmed: 3880610
J Thromb Haemost. 2011 Jul;9 Suppl 1:182-8
pubmed: 21781254
Colloids Surf B Biointerfaces. 2018 Jun 1;166:218-223
pubmed: 29597155
ACS Appl Mater Interfaces. 2016 Mar;8(10):6379-90
pubmed: 26909753
Adv Colloid Interface Sci. 2016 Mar;229:57-79
pubmed: 26792021
Adv Mater. 2018 Apr;30(14):e1706529
pubmed: 29484716
IEEE Trans Biomed Eng. 2012 May;59(5):1472-9
pubmed: 22410324
ACS Appl Mater Interfaces. 2012 May;4(5):2618-29
pubmed: 22489770
Int J Pharm. 2014 Mar 25;463(2):137-45
pubmed: 24211443
J Trauma. 2004 Jan;56(1):205-8
pubmed: 14749593
Adv Drug Deliv Rev. 2011 Sep 16;63(12):1031-41
pubmed: 21669239
J Mater Chem B. 2018 Oct 21;6(39):6225-6233
pubmed: 32254613
Biomaterials. 2008 Nov;29(32):4323-32
pubmed: 18708251

Auteurs

Zhe Li (Z)

Guangdong Provincial Key Laboratory of Sensor Technology and Biomedical Instrument, School of Biomedical Engineering, Sun Yat-Sen University, Guangzhou, 510006, China.
Department of Biomedical Engineering, National University of Singapore, Singapore, 117583, Singapore.

Athanasios Milionis (A)

Laboratory of Thermodynamics in Emerging Technologies, Department of Mechanical and Process Engineering, ETH Zurich, 8092, Zurich, Switzerland.

Yu Zheng (Y)

Department of Biomedical Engineering, National University of Singapore, Singapore, 117583, Singapore.

Marcus Yee (M)

Department of Biomedical Engineering, National University of Singapore, Singapore, 117583, Singapore.

Lukas Codispoti (L)

Laboratory of Thermodynamics in Emerging Technologies, Department of Mechanical and Process Engineering, ETH Zurich, 8092, Zurich, Switzerland.

Freddie Tan (F)

Department of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, 117585, Singapore.

Dimos Poulikakos (D)

Laboratory of Thermodynamics in Emerging Technologies, Department of Mechanical and Process Engineering, ETH Zurich, 8092, Zurich, Switzerland. dpoulikakos@ethz.ch.

Choon Hwai Yap (CH)

Department of Biomedical Engineering, National University of Singapore, Singapore, 117583, Singapore. bieyapc@nus.edu.sg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH